

Toxoplasmosis is an infection caused by the parasite Toxoplasma gondii (T. gondii). Humans can acquire this infection by eating undercooked contaminated meat, consuming food or water contaminated with oocysts, or through transplacental transmission from mother to child during pregnancy. In healthy individuals, toxoplasmosis often causes no noticeable symptoms or mild flu-like illnesses, such as swollen lymph nodes, body aches, or fatigue. However, the infection can pose serious risks to pregnant women and immunocompromised individuals.
During pregnancy, the timing of toxoplasmosis infection plays a crucial role. If the mother acquires a recent infection, it can be passed to the unborn baby and lead to congenital toxoplasmosis, which may cause serious complications such as miscarriage, hydrocephalus, seizures, or developmental delays. In people with weakened immune systems, a previously dormant infection can reactivate, potentially resulting in severe neurological or widespread systemic illness.
The Toxoplasma Avidity, IgG test provides more detailed information than a standard IgG antibody test. After initial infection, the immune system produces IgG antibodies with low avidity (weak binding). Over time, these antibodies mature and develop high avidity (strong binding). By analyzing this avidity, doctors can determine whether the infection is recent (within the last 3–4 months) or occurred in the distant past.
This test is commonly advised during pregnancy when IgG antibodies are detected, to rule out a recent infection and assess fetal risk. It is also recommended for individuals with weakened immune systems or when the results of routine antibody testing are unclear.
No special preparation is needed before taking this test. But it is important to inform your doctor about any medications you are taking or any recent infections, as these can affect results. During the test, details such as the specimen type, collection site, clinical history, and the clinician’s contact number are also required for accurate reporting and notification.
Test result ranges are approximate and may differ slightly between labs depending on the methodology and laboratory guidelines. Do not self-medicate and always consult a doctor to understand the test results correctly.
Please note: This is an outsourced test. The sample is collected by TATA 1MG and processed at a NABL accredited partnered lab.
The Toxoplasma Avidity, IgG test measures the binding strength of IgG antibodies against the Toxoplasma gondii parasite in the blood. After a new infection, IgG antibodies initially show low avidity, which typically suggests a recent infection within the last 3–4 months. Over time, as the immune response matures, the antibodies develop high avidity, usually indicating a past infection that occurred more than 4 months ago. A high-avidity result in pregnancy generally reduces the concern of transmitting the infection to the baby. By distinguishing recent from past infections, this test provides crucial information for doctors to make informed decisions in managing high-risk cases, especially in pregnant women and individuals with weakened immune systems.
The Toxoplasma Avidity, IgG test is done:
- To determine whether a toxoplasmosis infection is recent or occurred in the past
- During pregnancy, to assess the risk of congenital transmission
- In immunocompromised individuals, to evaluate the infection status
- In combination with Toxoplasma IgM and IgG tests, when results are inconclusive
- As part of the TORCH panel to screen for infections that may affect fetal health
- The specimen type, site, and clinical history are required. The clinician’s number is required for notification.
































